The study of our skin and the conditions that affect it is perpetually ongoing, with new discoveries and treatment methodologies coming to light every year. As such, the standardized guidelines for care must be regularly updated, particularly for conditions that affect significant percentages of the population and are being actively researched. 

Treatment Suggestions and Warnings for Atopic Dermatitis

After more than a decade since their last recommendations regarding the management of atopic dermatitis (AD), The American Academy and College of Allergy, Asthma and Immunology Joint Task Force released an updated guideline in 2023. This group of experts settled on 25 recommendations for the optimal treatment of mild, moderate and severe AD, which are broken up into five broad types: topical treatments, dilute bleach baths, dietary changes, allergen immunotherapy and systemic treatments. 

These new guidelines are based on trustworthy allergy guidelines, core involvement by both patients and caregivers to share their values and preferences, and the clear translation of evidence into clinically effective behavioral recommendations. In the past decade, a range of new therapeutic options have emerged, including various biologics, small molecule treatments, and an effective topical inhibitor.

Some of the new strategies involve the use of topical corticosteroids for those with uncontrolled AD, the use of crisaborole 2% topical corticosteroid for mild to moderate AD, and proactive therapy with TCS or TCI (topical calcineurin inhibitors) for those with frequent AD relapses. Furthermore, the guidelines recommend against the use of systemic corticosteroids, the use of topical antimicrobials without the presence of an infection, and the practice of elimination diets. This updated guide also provides a good practice statement for all clinicians dealing with the diagnosis and treatment of atopic dermatitis in their patients. For the full list of recommendations and warnings, check out the infographic here.

Hyaluronic Acid for Atopic Dermatitis

Although the Academy's recommendations don't specifically mention the use of hyaluronic acid for the treatment of atopic dermatitis (eczema), anti-inflammatories and moisturizers are recommended, along with the proactive treatment of problem spots and twice-daily application of topical creams, when necessary. 

Hyaluronic acid is a glycosaminoglycan that occurs naturally in the body, and is concentrated in the joints, eyes, and skin. This powerful emollient helps to keep these key areas of the body lubricated and hydrated, but as we age, our bodies produce less and less of this critical substance. The topical use of hyaluronic acid has become increasingly popular in recent years for a variety of skin conditions, from atopic dermatitis and acne to rosacea and chronically dry skin. 

In the case of eczema, hyaluronic acid addresses some of the most prominent symptoms—dry and flaking skin, as well as itchiness, redness and inflammation. Hyaluronic acid helps to hold moisture on the skin, soothing the irritation, reducing the impact of cytokines at the site, and stimulating tissue regeneration. 

A “Neu” Treatment for Atopic Dermatitis

For those seeking an affordable and carefully engineered solution for their eczema symptoms, the Day and Night Cream from NeuLuna is an excellent option. With hyaluronic acid as its primary active ingredient, supported by rosehip oil and oleyl erucate, this cream features a patented delivery system that penetrates deep into your skin. This novel formulation is non-abrasive, soothing and readily absorbs into the skin without an oily residue. 

If you suffer from severe eczema symptoms, multiple applications of the cream may be required throughout the day for consistent relief, but we recommend twice-daily applications for mild to moderate cases.